Evidence map›Paper›PMID 37404211›Full record

ArticleFlorence Nightingale journal of nursing2023

Diagnosis Rates Through Cancer Screening Programs in Patients with Breast Carcinoma.

Mustafa Eray Kılıç, Sena Özcan, Göksu Kılıç, Betül Bolat Küçükzeybek, Yusuf Atmalar, Badesu Talia Koç

Open access · diamondAbstract read
In one paragraph

Article in Florence Nightingale journal of nursing, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Mustafa Eray KılıçDokuz Eylül University, Faculty of Medicine, İzmir, Turkey.
Sena Özcanİzmir Katip Çelebi University, Faculty of Medicine, İzmir, Turkey.
Göksu Kılıçİzmir Katip Çelebi University, Faculty of Medicine, İzmir, Turkey.
Betül Bolat KüçükzeybekDepartment of Pathology, İzmir Katip Celebi University, İzmir, Turkey.
Yusuf Atmalarİzmir Katip Çelebi University, Faculty of Medicine, İzmir, Turkey.
Badesu Talia Koçİzmir Katip Çelebi University, Faculty of Medicine, İzmir, Turkey.
Dokuz Eylül University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimThis study investigated whether breast cancer patients had ever applied for Cancer Early Diagnosis Screening and Training Centers (KETEM).

methodThis study, conducted from November 2020 to April 2021, adopts a cross-sectional research design and is planned as a survey study. The "Diagnosis Rates with Screening Programs in Breast Cancer Patients" survey was conducted on women over 45 who were diagnosed with breast cancer in the Medical Oncology Clinic of İzmir Katip Çelebi University Atatürk Education and Research Hospital. Further information about the cancer stage was gathered from the Medical Oncology outpatient clinic file records. Data obtained in the study were evaluated using the the Statistical Package for Social Sciences version 26.0 software (IBM Corp.; Armonk, NY, USA), using the number, percentage distribution, arithmetic mean, and chi-square test methods.

resultsIt has been determined that most patients diagnosed did not receive a diagnosis through screening programs, were not aware of KETEM, and did not apply to KETEM. A positive relationship was found between the level of education and participation in screening programs. It was observed that women who knew about the KETEM's participated more often in the scans.

conclusionThe study discovered a lack of knowledge and inadequacy in screening programs for patients with breast cancer. We believe that it is essential to introduce and disseminate KETEMs so that cancers can be detected early through screening.

Identifiers

PMID37404211
PMCPMC10440967
OpenAlexW4382461977

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.